Colorectal Cancer Trial, Recruiting NCT00843375 Sponsor: University of Michigan Rogel Cancer Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT00843375
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be willing to sign a consent form to take part in the study
  • You must be able to have up to 60 ml of blood drawn (about 4 tablespoons) without it being a health risk for you
  • You must be 18 years old or older
  • You must be willing to collect 1 to 2 stool samples and complete a stool blood test (called a FIT test)
  • Nursing mothers who meet all other requirements may be able to join
  • You must fall into one of these groups: you have colorectal cancer that has not yet been treated; you have a confirmed non-cancerous colon growth (adenoma) currently in your colon; you are at higher risk due to a past history of colon growths or colorectal cancer (more than 3 years ago), a close family member (parent, sibling, or child) who has had colorectal cancer, or a recent positive stool screening test with no follow-up yet; or you have no personal or family history of colorectal cancer or growths and are considered average risk
  • People who had colorectal cancer that was successfully treated at least 3 years ago may also be eligible depending on their current situation (confirm with trial site)
  • People whose colonoscopy found certain non-cancerous polyp types (such as hyperplastic polyps, lipomas, or inflammatory polyps) may also qualify depending on other criteria (confirm with trial site)

Who may not be able to join:

  • You cannot join if you have already had surgery, radiation, or chemotherapy for your current colorectal cancer before your stool samples are collected
  • You cannot join if you have been diagnosed with Inflammatory Bowel Disease (such as Crohn's disease or ulcerative colitis), whether currently active or in your past medical history
  • You cannot join if you have a known inherited colorectal cancer condition called HNPCC (Lynch syndrome) or FAP (confirm with trial site if unsure)
  • You cannot join if you are unable to understand or agree to the consent form
  • You cannot join if you have had another active cancer within the last 3 years, unless it was a specific type of skin cancer, an early-stage cervical cancer treated with surgery only, or an early-stage uterine cancer treated with surgery (confirm with trial site for details)
  • You cannot join if you are currently receiving chemotherapy or radiation treatment for any reason
  • You cannot join if you are known to have HIV or chronic active viral hepatitis
  • You cannot join if you are currently pregnant
  • You cannot join if your colon examination was done using a CT scan (virtual colonoscopy) rather than a standard colonoscopy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dean E Brenner, M.D., University of Michigan

Phone: 1-800-865-1125

Australian sites

Flinders Medical Center, Adelaide, South Australia

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Michigan Rogel Cancer Center
Registry
ClinicalTrials.gov
Start date
7 August 2019
Est. completion
1 March 2028

Where this trial is recruiting

🇦🇺 Australia 🇨🇦 Canada 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Biospecimen Retention: Samples with DNA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov